John Rinn
Concepts (587)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 65 | 2025 | 172 | 16.740 |
Why?
| | RNA, Untranslated | 27 | 2021 | 121 | 5.800 |
Why?
| | Gene Expression Regulation | 49 | 2024 | 2588 | 4.290 |
Why?
| | Chromatin | 26 | 2023 | 553 | 3.590 |
Why?
| | RNA | 18 | 2026 | 910 | 2.830 |
Why?
| | Cell Nucleus | 14 | 2025 | 587 | 2.440 |
Why?
| | Transcription, Genetic | 29 | 2024 | 1454 | 2.260 |
Why?
| | Genome | 12 | 2022 | 304 | 2.150 |
Why?
| | Genome, Human | 18 | 2021 | 419 | 2.070 |
Why?
| | Epigenesis, Genetic | 18 | 2024 | 672 | 2.060 |
Why?
| | RNA-Binding Proteins | 16 | 2026 | 447 | 1.910 |
Why?
| | Enhancer Elements, Genetic | 10 | 2020 | 191 | 1.840 |
Why?
| | Promoter Regions, Genetic | 16 | 2021 | 1244 | 1.820 |
Why?
| | RNA, Messenger | 25 | 2021 | 2803 | 1.820 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2017 | 532 | 1.760 |
Why?
| | Repetitive Sequences, Nucleic Acid | 3 | 2021 | 117 | 1.570 |
Why?
| | Models, Genetic | 8 | 2018 | 523 | 1.560 |
Why?
| | Cell Differentiation | 26 | 2025 | 2040 | 1.410 |
Why?
| | Sequence Analysis, RNA | 14 | 2019 | 442 | 1.340 |
Why?
| | Ribonucleoproteins | 4 | 2025 | 89 | 1.320 |
Why?
| | Transcriptome | 12 | 2025 | 1029 | 1.290 |
Why?
| | Telomerase | 4 | 2024 | 246 | 1.270 |
Why?
| | X Chromosome Inactivation | 6 | 2024 | 25 | 1.260 |
Why?
| | Gene Deletion | 6 | 2021 | 391 | 1.260 |
Why?
| | Animals | 93 | 2025 | 37952 | 1.210 |
Why?
| | Introns | 6 | 2025 | 253 | 1.180 |
Why?
| | CCCTC-Binding Factor | 3 | 2024 | 12 | 1.170 |
Why?
| | Fibroblasts | 10 | 2018 | 1022 | 1.090 |
Why?
| | Base Sequence | 18 | 2020 | 2168 | 1.090 |
Why?
| | Mice | 61 | 2025 | 18303 | 1.090 |
Why?
| | Open Reading Frames | 8 | 2024 | 128 | 1.050 |
Why?
| | Genomics | 13 | 2022 | 819 | 1.040 |
Why?
| | Chromosomes | 3 | 2018 | 106 | 1.010 |
Why?
| | DNA, Complementary | 8 | 2020 | 273 | 1.010 |
Why?
| | Genetic Loci | 7 | 2020 | 258 | 0.990 |
Why?
| | Embryonic Stem Cells | 10 | 2015 | 124 | 0.980 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 35 | 0.970 |
Why?
| | RNA Splicing | 7 | 2025 | 284 | 0.930 |
Why?
| | RNA, Nuclear | 1 | 2025 | 5 | 0.930 |
Why?
| | Gene Expression Regulation, Developmental | 16 | 2023 | 909 | 0.900 |
Why?
| | Transcription Factors | 17 | 2020 | 1731 | 0.850 |
Why?
| | Molecular Sequence Annotation | 7 | 2020 | 104 | 0.850 |
Why?
| | Gene Expression Profiling | 29 | 2020 | 1763 | 0.840 |
Why?
| | Hematopoiesis | 3 | 2021 | 193 | 0.820 |
Why?
| | Mice, Knockout | 15 | 2025 | 3114 | 0.800 |
Why?
| | Humans | 123 | 2026 | 145140 | 0.800 |
Why?
| | Cell Line | 17 | 2024 | 2821 | 0.790 |
Why?
| | DNA Damage | 2 | 2017 | 435 | 0.780 |
Why?
| | Induced Pluripotent Stem Cells | 7 | 2021 | 272 | 0.760 |
Why?
| | Microscopy, Confocal | 3 | 2018 | 318 | 0.730 |
Why?
| | Fertility | 2 | 2020 | 173 | 0.720 |
Why?
| | Pluripotent Stem Cells | 6 | 2022 | 82 | 0.710 |
Why?
| | Regulatory Elements, Transcriptional | 4 | 2020 | 18 | 0.700 |
Why?
| | Binding Sites | 13 | 2024 | 1309 | 0.700 |
Why?
| | Polycomb Repressive Complex 2 | 5 | 2020 | 79 | 0.670 |
Why?
| | Computational Biology | 7 | 2021 | 669 | 0.670 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2026 | 530 | 0.660 |
Why?
| | Cellular Reprogramming | 4 | 2018 | 98 | 0.650 |
Why?
| | Cytoplasm | 3 | 2022 | 254 | 0.650 |
Why?
| | Evolution, Molecular | 4 | 2020 | 490 | 0.650 |
Why?
| | Hemorrhagic Fever, Ebola | 4 | 2023 | 82 | 0.640 |
Why?
| | Ebolavirus | 4 | 2023 | 91 | 0.640 |
Why?
| | Sequence Deletion | 3 | 2020 | 190 | 0.640 |
Why?
| | DNA | 7 | 2022 | 1433 | 0.630 |
Why?
| | Body Patterning | 4 | 2008 | 138 | 0.620 |
Why?
| | Nucleic Acid Conformation | 7 | 2024 | 723 | 0.620 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2020 | 2136 | 0.600 |
Why?
| | K562 Cells | 5 | 2021 | 92 | 0.600 |
Why?
| | Embryonic Development | 6 | 2019 | 125 | 0.590 |
Why?
| | Repressor Proteins | 7 | 2018 | 429 | 0.580 |
Why?
| | Oligonucleotide Array Sequence Analysis | 17 | 2016 | 749 | 0.580 |
Why?
| | Alleles | 6 | 2024 | 888 | 0.580 |
Why?
| | DNA-Binding Proteins | 7 | 2021 | 1479 | 0.580 |
Why?
| | In Situ Hybridization, Fluorescence | 7 | 2021 | 323 | 0.580 |
Why?
| | Organ Specificity | 6 | 2019 | 308 | 0.560 |
Why?
| | Molecular Sequence Data | 10 | 2015 | 2881 | 0.550 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 776 | 0.550 |
Why?
| | Chromosomes, Human | 1 | 2018 | 42 | 0.540 |
Why?
| | Time-Lapse Imaging | 1 | 2018 | 21 | 0.540 |
Why?
| | Endogenous Retroviruses | 2 | 2022 | 37 | 0.530 |
Why?
| | Chromosomes, Human, X | 1 | 2018 | 76 | 0.530 |
Why?
| | Chromosome Aberrations | 1 | 2018 | 165 | 0.530 |
Why?
| | DNA Methylation | 8 | 2022 | 667 | 0.520 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 451 | 0.510 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2019 | 1442 | 0.490 |
Why?
| | Phenotype | 8 | 2024 | 3138 | 0.480 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 105 | 0.470 |
Why?
| | Genomic Imprinting | 3 | 2024 | 26 | 0.470 |
Why?
| | DNA, Satellite | 1 | 2015 | 18 | 0.460 |
Why?
| | DNA, Intergenic | 4 | 2011 | 26 | 0.460 |
Why?
| | Homeodomain Proteins | 6 | 2013 | 522 | 0.460 |
Why?
| | Gene Regulatory Networks | 7 | 2018 | 317 | 0.460 |
Why?
| | Genes, Homeobox | 5 | 2013 | 50 | 0.450 |
Why?
| | Plasmodium falciparum | 2 | 2015 | 37 | 0.450 |
Why?
| | Centromere | 1 | 2015 | 61 | 0.450 |
Why?
| | Protein Binding | 13 | 2026 | 2235 | 0.430 |
Why?
| | Neoplasms | 5 | 2019 | 2900 | 0.430 |
Why?
| | DNA Transposable Elements | 1 | 2014 | 124 | 0.400 |
Why?
| | Nuclear Proteins | 3 | 2016 | 738 | 0.400 |
Why?
| | X Chromosome | 3 | 2024 | 65 | 0.390 |
Why?
| | Myoblasts | 3 | 2022 | 83 | 0.390 |
Why?
| | HeLa Cells | 8 | 2021 | 631 | 0.390 |
Why?
| | Systems Biology | 3 | 2011 | 68 | 0.390 |
Why?
| | Immunoprecipitation | 3 | 2026 | 148 | 0.390 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 145 | 0.380 |
Why?
| | Proteins | 7 | 2024 | 1022 | 0.380 |
Why?
| | RNA Interference | 7 | 2021 | 474 | 0.380 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2014 | 167 | 0.370 |
Why?
| | Adipogenesis | 1 | 2013 | 56 | 0.370 |
Why?
| | Retroelements | 1 | 2012 | 50 | 0.370 |
Why?
| | HEK293 Cells | 7 | 2021 | 740 | 0.370 |
Why?
| | Cells, Cultured | 16 | 2021 | 4142 | 0.370 |
Why?
| | Homeostasis | 4 | 2021 | 639 | 0.360 |
Why?
| | Skin | 2 | 2008 | 753 | 0.360 |
Why?
| | Brain | 2 | 2015 | 2934 | 0.350 |
Why?
| | Epidermis | 2 | 2012 | 156 | 0.340 |
Why?
| | RNA Stability | 5 | 2021 | 107 | 0.340 |
Why?
| | Human Embryonic Stem Cells | 2 | 2021 | 24 | 0.330 |
Why?
| | High-Throughput Screening Assays | 3 | 2026 | 175 | 0.330 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 2023 | 92 | 0.330 |
Why?
| | Conserved Sequence | 6 | 2020 | 244 | 0.320 |
Why?
| | Down-Regulation | 3 | 2016 | 618 | 0.320 |
Why?
| | Histones | 11 | 2021 | 665 | 0.320 |
Why?
| | Muscle Development | 3 | 2022 | 112 | 0.310 |
Why?
| | Mouse Embryonic Stem Cells | 3 | 2020 | 36 | 0.300 |
Why?
| | Chromosomes, Human, Pair 22 | 4 | 2004 | 48 | 0.300 |
Why?
| | Gene Library | 4 | 2018 | 122 | 0.300 |
Why?
| | Telomere | 2 | 2019 | 287 | 0.300 |
Why?
| | MicroRNAs | 8 | 2021 | 686 | 0.290 |
Why?
| | Sex Characteristics | 2 | 2005 | 775 | 0.290 |
Why?
| | Single-Cell Analysis | 5 | 2020 | 361 | 0.290 |
Why?
| | Mammals | 5 | 2021 | 284 | 0.290 |
Why?
| | Gene Editing | 2 | 2021 | 89 | 0.290 |
Why?
| | CRISPR-Cas Systems | 3 | 2021 | 166 | 0.280 |
Why?
| | Nucleotide Motifs | 3 | 2017 | 36 | 0.280 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2207 | 0.270 |
Why?
| | Immunity, Innate | 3 | 2019 | 834 | 0.260 |
Why?
| | Cell Lineage | 5 | 2021 | 377 | 0.260 |
Why?
| | Lymphopoiesis | 2 | 2021 | 27 | 0.260 |
Why?
| | Chromatin Assembly and Disassembly | 5 | 2017 | 108 | 0.260 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 36 | 0.250 |
Why?
| | Wnt Proteins | 1 | 2008 | 133 | 0.250 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 3 | 2022 | 16 | 0.240 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3410 | 0.240 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 864 | 0.230 |
Why?
| | HCT116 Cells | 3 | 2021 | 76 | 0.230 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 307 | 0.230 |
Why?
| | Exons | 4 | 2016 | 363 | 0.220 |
Why?
| | Databases, Genetic | 4 | 2020 | 238 | 0.220 |
Why?
| | Genes, X-Linked | 1 | 2024 | 21 | 0.220 |
Why?
| | Myosin Heavy Chains | 2 | 2021 | 183 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 1 | 2008 | 623 | 0.210 |
Why?
| | Genitalia | 1 | 2004 | 33 | 0.210 |
Why?
| | Gene Knockdown Techniques | 4 | 2013 | 333 | 0.210 |
Why?
| | Motor Neurons | 3 | 2015 | 236 | 0.210 |
Why?
| | Male | 21 | 2024 | 72664 | 0.210 |
Why?
| | Signal Transduction | 11 | 2021 | 5208 | 0.200 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2023 | 16 | 0.200 |
Why?
| | Immunologic Memory | 1 | 2025 | 368 | 0.190 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2019 | 881 | 0.190 |
Why?
| | Cluster Analysis | 5 | 2015 | 500 | 0.190 |
Why?
| | Alternative Splicing | 2 | 2018 | 247 | 0.190 |
Why?
| | Databases, Nucleic Acid | 2 | 2021 | 38 | 0.190 |
Why?
| | Plasmids | 1 | 2023 | 373 | 0.180 |
Why?
| | NF-kappa B | 4 | 2020 | 664 | 0.180 |
Why?
| | Zebrafish | 4 | 2013 | 532 | 0.180 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 170 | 0.180 |
Why?
| | Female | 23 | 2024 | 78636 | 0.180 |
Why?
| | Mitosis | 2 | 2021 | 193 | 0.180 |
Why?
| | Ribonucleases | 2 | 2019 | 48 | 0.180 |
Why?
| | RNA Transport | 3 | 2016 | 27 | 0.180 |
Why?
| | Gene Targeting | 1 | 2021 | 80 | 0.170 |
Why?
| | Genetic Techniques | 2 | 2013 | 66 | 0.170 |
Why?
| | Mice, Inbred Strains | 2 | 2019 | 396 | 0.170 |
Why?
| | Ectoderm | 1 | 2021 | 53 | 0.170 |
Why?
| | Mice, Inbred C57BL | 11 | 2025 | 5972 | 0.170 |
Why?
| | Genetic Association Studies | 3 | 2014 | 367 | 0.170 |
Why?
| | Research Report | 1 | 2021 | 86 | 0.170 |
Why?
| | Cell Compartmentation | 1 | 2021 | 52 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 977 | 0.170 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2022 | 212 | 0.170 |
Why?
| | Cardiac Myosins | 1 | 2021 | 37 | 0.170 |
Why?
| | Stem Cells | 3 | 2022 | 624 | 0.170 |
Why?
| | Receptor, Insulin | 1 | 2021 | 93 | 0.160 |
Why?
| | Ikaros Transcription Factor | 1 | 2021 | 23 | 0.160 |
Why?
| | Epigenomics | 2 | 2011 | 112 | 0.160 |
Why?
| | Lipopolysaccharides | 3 | 2019 | 858 | 0.160 |
Why?
| | Polycomb-Group Proteins | 3 | 2010 | 36 | 0.160 |
Why?
| | Eukaryotic Cells | 1 | 2020 | 35 | 0.160 |
Why?
| | Spermatogenesis | 1 | 2020 | 91 | 0.160 |
Why?
| | Telomere Homeostasis | 1 | 2020 | 33 | 0.160 |
Why?
| | Placenta | 3 | 2021 | 784 | 0.160 |
Why?
| | Congresses as Topic | 1 | 2021 | 223 | 0.160 |
Why?
| | Species Specificity | 1 | 2021 | 545 | 0.150 |
Why?
| | RNA Precursors | 1 | 2021 | 154 | 0.150 |
Why?
| | Protein Domains | 2 | 2020 | 311 | 0.150 |
Why?
| | Genome-Wide Association Study | 4 | 2020 | 1376 | 0.150 |
Why?
| | Preimplantation Diagnosis | 1 | 2019 | 7 | 0.150 |
Why?
| | Dactinomycin | 1 | 2019 | 23 | 0.150 |
Why?
| | RNA Processing, Post-Transcriptional | 3 | 2018 | 90 | 0.150 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 67 | 0.150 |
Why?
| | Embryo Implantation | 1 | 2019 | 34 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 917 | 0.150 |
Why?
| | Apoptosis | 4 | 2018 | 2434 | 0.150 |
Why?
| | Drug Tolerance | 1 | 2019 | 99 | 0.150 |
Why?
| | Organelles | 2 | 2017 | 55 | 0.150 |
Why?
| | RNA, Fungal | 2 | 2010 | 67 | 0.140 |
Why?
| | Structure-Activity Relationship | 1 | 2020 | 563 | 0.140 |
Why?
| | Pattern Recognition, Automated | 1 | 2019 | 74 | 0.140 |
Why?
| | Fertilization in Vitro | 1 | 2019 | 104 | 0.140 |
Why?
| | Protein Conformation | 2 | 2021 | 936 | 0.140 |
Why?
| | Transgenes | 3 | 2020 | 190 | 0.140 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2018 | 21 | 0.140 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2018 | 28 | 0.140 |
Why?
| | Mutation | 6 | 2024 | 4071 | 0.140 |
Why?
| | Binding, Competitive | 2 | 2020 | 185 | 0.140 |
Why?
| | Cell Proliferation | 7 | 2020 | 2504 | 0.140 |
Why?
| | Time Factors | 4 | 2024 | 7107 | 0.140 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2018 | 54 | 0.140 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 267 | 0.140 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 3539 | 0.140 |
Why?
| | Adipocytes | 1 | 2020 | 223 | 0.140 |
Why?
| | HMGA2 Protein | 1 | 2018 | 10 | 0.140 |
Why?
| | Molecular Imaging | 1 | 2018 | 57 | 0.140 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2017 | 337 | 0.140 |
Why?
| | Cell Nucleolus | 1 | 2018 | 19 | 0.140 |
Why?
| | Cyclooxygenase 2 | 1 | 2018 | 166 | 0.130 |
Why?
| | Lymphocytes | 2 | 2017 | 376 | 0.130 |
Why?
| | Immunity | 1 | 2018 | 140 | 0.130 |
Why?
| | Macaca mulatta | 3 | 2023 | 186 | 0.130 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2018 | 142 | 0.130 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 263 | 0.130 |
Why?
| | Consensus Sequence | 2 | 2016 | 73 | 0.130 |
Why?
| | Translocation, Genetic | 1 | 2018 | 119 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2021 | 265 | 0.130 |
Why?
| | Pyramidal Tracts | 2 | 2014 | 30 | 0.130 |
Why?
| | Retinal Pigment Epithelium | 1 | 2018 | 79 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 361 | 0.130 |
Why?
| | Staining and Labeling | 1 | 2017 | 153 | 0.130 |
Why?
| | Splicing Factor U2AF | 1 | 2016 | 18 | 0.120 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2016 | 37 | 0.120 |
Why?
| | Histone Deacetylases | 1 | 2018 | 207 | 0.120 |
Why?
| | Genotype | 1 | 2021 | 1844 | 0.120 |
Why?
| | Histocompatibility, Maternal-Fetal | 1 | 2016 | 2 | 0.120 |
Why?
| | HLA-G Antigens | 1 | 2016 | 2 | 0.120 |
Why?
| | Genetic Testing | 1 | 2019 | 480 | 0.120 |
Why?
| | Kidney | 1 | 2004 | 1494 | 0.120 |
Why?
| | Support Vector Machine | 1 | 2016 | 33 | 0.120 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 108 | 0.120 |
Why?
| | GTP-Binding Protein gamma Subunits | 1 | 2016 | 10 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 777 | 0.120 |
Why?
| | Chromatin Assembly Factor-1 | 1 | 2015 | 12 | 0.120 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2016 | 117 | 0.120 |
Why?
| | Myocardium | 1 | 2021 | 931 | 0.120 |
Why?
| | Methylation | 5 | 2020 | 242 | 0.110 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2015 | 18 | 0.110 |
Why?
| | PTEN Phosphohydrolase | 2 | 2016 | 165 | 0.110 |
Why?
| | rho GTP-Binding Proteins | 1 | 2016 | 56 | 0.110 |
Why?
| | Immunohistochemistry | 3 | 2015 | 1713 | 0.110 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 250 | 0.110 |
Why?
| | Gene Expression | 4 | 2015 | 1474 | 0.110 |
Why?
| | Chondrocytes | 1 | 2018 | 231 | 0.110 |
Why?
| | Liver | 1 | 2004 | 1893 | 0.110 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2015 | 24 | 0.110 |
Why?
| | Nervous System | 1 | 2015 | 69 | 0.110 |
Why?
| | Pseudogenes | 2 | 2014 | 20 | 0.110 |
Why?
| | Genes | 1 | 2015 | 226 | 0.110 |
Why?
| | Myeloid Cells | 1 | 2016 | 146 | 0.110 |
Why?
| | beta-Galactosidase | 1 | 2015 | 76 | 0.110 |
Why?
| | RNA, Protozoan | 1 | 2015 | 60 | 0.110 |
Why?
| | Doxorubicin | 1 | 2017 | 396 | 0.110 |
Why?
| | STAT3 Transcription Factor | 1 | 2016 | 206 | 0.110 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 170 | 0.110 |
Why?
| | Gene Silencing | 2 | 2013 | 202 | 0.110 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 431 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 418 | 0.110 |
Why?
| | Erythrocytes | 1 | 2020 | 747 | 0.110 |
Why?
| | RNA, Catalytic | 1 | 2015 | 191 | 0.110 |
Why?
| | Kinetics | 1 | 2018 | 1567 | 0.110 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 118 | 0.110 |
Why?
| | Molecular Biology | 1 | 2015 | 57 | 0.110 |
Why?
| | Lysine | 3 | 2020 | 304 | 0.110 |
Why?
| | Pyramidal Cells | 1 | 2014 | 80 | 0.100 |
Why?
| | Neocortex | 1 | 2014 | 49 | 0.100 |
Why?
| | Protein Footprinting | 1 | 2014 | 11 | 0.100 |
Why?
| | Neurotransmitter Agents | 1 | 2014 | 83 | 0.100 |
Why?
| | Keratinocytes | 2 | 2012 | 249 | 0.100 |
Why?
| | Neurons | 2 | 2021 | 1644 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2018 | 686 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 37 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 573 | 0.100 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2011 | 156 | 0.100 |
Why?
| | Trophoblasts | 1 | 2016 | 218 | 0.100 |
Why?
| | Pregnancy | 4 | 2023 | 7182 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 1138 | 0.100 |
Why?
| | Nerve Tissue Proteins | 2 | 2014 | 589 | 0.100 |
Why?
| | Information Theory | 1 | 2013 | 5 | 0.100 |
Why?
| | Neuronal Plasticity | 1 | 2015 | 305 | 0.090 |
Why?
| | Fetus | 1 | 2017 | 804 | 0.090 |
Why?
| | Nervous System Diseases | 1 | 2015 | 286 | 0.090 |
Why?
| | Protein Array Analysis | 1 | 2012 | 56 | 0.090 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 71 | 0.090 |
Why?
| | Inhibitor of Differentiation Protein 2 | 2 | 2025 | 5 | 0.090 |
Why?
| | Ubiquitination | 1 | 2013 | 118 | 0.090 |
Why?
| | Mice, Transgenic | 5 | 2020 | 2185 | 0.090 |
Why?
| | Adipocytes, Brown | 1 | 2012 | 8 | 0.090 |
Why?
| | Models, Biological | 1 | 2019 | 1763 | 0.090 |
Why?
| | Adipocytes, White | 1 | 2012 | 19 | 0.090 |
Why?
| | Genes, Overlapping | 1 | 2011 | 2 | 0.090 |
Why?
| | Biological Evolution | 1 | 2015 | 466 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 193 | 0.090 |
Why?
| | Genome, Protozoan | 1 | 2011 | 2 | 0.090 |
Why?
| | Genes, Protozoan | 1 | 2011 | 13 | 0.090 |
Why?
| | Registries | 1 | 2020 | 2401 | 0.080 |
Why?
| | Disease | 1 | 2012 | 96 | 0.080 |
Why?
| | Models, Statistical | 2 | 2024 | 671 | 0.080 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 5 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2011 | 362 | 0.080 |
Why?
| | Artifacts | 1 | 2011 | 143 | 0.080 |
Why?
| | Mitochondria | 2 | 2020 | 992 | 0.080 |
Why?
| | Colonic Neoplasms | 1 | 2013 | 257 | 0.080 |
Why?
| | Argonaute Proteins | 3 | 2016 | 32 | 0.080 |
Why?
| | Sexual Maturation | 1 | 2010 | 48 | 0.080 |
Why?
| | Octamer Transcription Factor-3 | 2 | 2021 | 19 | 0.080 |
Why?
| | Body Size | 1 | 2010 | 88 | 0.080 |
Why?
| | Insulin | 2 | 2018 | 2510 | 0.070 |
Why?
| | Thymus Gland | 2 | 2008 | 311 | 0.070 |
Why?
| | Adenocarcinoma | 1 | 2016 | 920 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 2 | 2010 | 572 | 0.070 |
Why?
| | Prostatic Neoplasms | 1 | 2016 | 978 | 0.070 |
Why?
| | Chromosome Mapping | 3 | 2004 | 504 | 0.070 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2008 | 18 | 0.070 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2009 | 72 | 0.070 |
Why?
| | Myosin Type V | 1 | 2008 | 9 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2010 | 236 | 0.070 |
Why?
| | Wnt-5a Protein | 1 | 2008 | 24 | 0.070 |
Why?
| | Chromosome Disorders | 1 | 2008 | 47 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2009 | 320 | 0.070 |
Why?
| | Proteome | 1 | 2012 | 512 | 0.070 |
Why?
| | Zebrafish Proteins | 2 | 2010 | 314 | 0.070 |
Why?
| | Bacteria | 2 | 2013 | 765 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 2127 | 0.070 |
Why?
| | Cell Survival | 3 | 2016 | 1100 | 0.060 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 688 | 0.060 |
Why?
| | Keratins | 1 | 2008 | 171 | 0.060 |
Why?
| | Viruses | 1 | 2009 | 164 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2020 | 277 | 0.060 |
Why?
| | Autoantigens | 2 | 2008 | 427 | 0.060 |
Why?
| | Zinc Fingers | 1 | 2007 | 50 | 0.060 |
Why?
| | Retinol-Binding Proteins | 1 | 2006 | 17 | 0.060 |
Why?
| | Epithelium | 1 | 2008 | 310 | 0.060 |
Why?
| | Peptides | 1 | 2012 | 997 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 174 | 0.060 |
Why?
| | ras Proteins | 1 | 2007 | 150 | 0.060 |
Why?
| | Software | 1 | 2012 | 678 | 0.060 |
Why?
| | Protozoan Proteins | 1 | 2007 | 90 | 0.060 |
Why?
| | Wound Healing | 1 | 2009 | 354 | 0.060 |
Why?
| | Eye Proteins | 1 | 2006 | 92 | 0.060 |
Why?
| | Algorithms | 1 | 2014 | 1845 | 0.060 |
Why?
| | Breast Neoplasms | 2 | 2016 | 2380 | 0.060 |
Why?
| | Dendritic Cells | 1 | 2009 | 496 | 0.060 |
Why?
| | Up-Regulation | 2 | 2020 | 846 | 0.060 |
Why?
| | Lectins, C-Type | 1 | 2025 | 59 | 0.060 |
Why?
| | Monocytes | 2 | 2020 | 537 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2006 | 335 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2021 | 634 | 0.060 |
Why?
| | T-Box Domain Proteins | 1 | 2025 | 106 | 0.050 |
Why?
| | Quantitative Trait Loci | 2 | 2020 | 375 | 0.050 |
Why?
| | Neoplastic Stem Cells | 1 | 2009 | 409 | 0.050 |
Why?
| | Transcortin | 1 | 2004 | 14 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2025 | 208 | 0.050 |
Why?
| | Levivirus | 1 | 2024 | 18 | 0.050 |
Why?
| | Serpins | 1 | 2004 | 28 | 0.050 |
Why?
| | Biophysical Phenomena | 1 | 2024 | 67 | 0.050 |
Why?
| | RNA Polymerase II | 2 | 2023 | 350 | 0.050 |
Why?
| | Metabolic Clearance Rate | 1 | 2004 | 115 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2008 | 414 | 0.050 |
Why?
| | Testis | 1 | 2004 | 162 | 0.050 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 146 | 0.050 |
Why?
| | Hypothalamus | 1 | 2004 | 163 | 0.050 |
Why?
| | Virus Internalization | 1 | 2023 | 65 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2016 | 139 | 0.050 |
Why?
| | Endoderm | 1 | 2023 | 21 | 0.050 |
Why?
| | SOXF Transcription Factors | 1 | 2023 | 16 | 0.050 |
Why?
| | Selection, Genetic | 1 | 2005 | 259 | 0.050 |
Why?
| | Poly A | 1 | 2003 | 50 | 0.050 |
Why?
| | Autoimmune Diseases | 1 | 2006 | 468 | 0.050 |
Why?
| | Ovary | 1 | 2004 | 231 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2022 | 17 | 0.050 |
Why?
| | Cytoskeletal Proteins | 2 | 2012 | 156 | 0.040 |
Why?
| | Neoplasm Invasiveness | 2 | 2016 | 506 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 372 | 0.040 |
Why?
| | Histone Demethylases | 2 | 2015 | 38 | 0.040 |
Why?
| | RNA, Small Untranslated | 1 | 2021 | 14 | 0.040 |
Why?
| | Macrophages | 2 | 2020 | 1500 | 0.040 |
Why?
| | Primates | 1 | 2022 | 133 | 0.040 |
Why?
| | Smad1 Protein | 1 | 2020 | 17 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2020 | 10 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 219 | 0.040 |
Why?
| | Oligonucleotide Probes | 2 | 2015 | 48 | 0.040 |
Why?
| | Cochlear Nucleus | 1 | 2000 | 5 | 0.040 |
Why?
| | Gene Ontology | 1 | 2020 | 53 | 0.040 |
Why?
| | Bystander Effect | 1 | 2020 | 19 | 0.040 |
Why?
| | Disease Models, Animal | 4 | 2017 | 4552 | 0.040 |
Why?
| | DNA Replication Timing | 1 | 2020 | 4 | 0.040 |
Why?
| | DNA Footprinting | 1 | 2020 | 33 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 135 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 207 | 0.040 |
Why?
| | Transposases | 1 | 2020 | 18 | 0.040 |
Why?
| | Deoxyribonuclease I | 1 | 2020 | 41 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1092 | 0.040 |
Why?
| | CpG Islands | 2 | 2015 | 161 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 171 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2000 | 55 | 0.040 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2020 | 93 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 690 | 0.040 |
Why?
| | Genetic Variation | 1 | 2005 | 967 | 0.040 |
Why?
| | Static Electricity | 1 | 2020 | 114 | 0.040 |
Why?
| | Cell Respiration | 1 | 2020 | 105 | 0.040 |
Why?
| | Karyotype | 1 | 2019 | 19 | 0.040 |
Why?
| | Karyotyping | 1 | 2019 | 105 | 0.040 |
Why?
| | Potassium Channels | 1 | 2000 | 147 | 0.040 |
Why?
| | Blastocyst | 1 | 2019 | 50 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 186 | 0.040 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 364 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 265 | 0.040 |
Why?
| | Cell Movement | 2 | 2016 | 959 | 0.040 |
Why?
| | Interphase | 1 | 2018 | 38 | 0.030 |
Why?
| | HL-60 Cells | 1 | 2018 | 30 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2014 | 1159 | 0.030 |
Why?
| | Regenerative Medicine | 1 | 2018 | 48 | 0.030 |
Why?
| | Genes, Switch | 1 | 2018 | 6 | 0.030 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 12 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 380 | 0.030 |
Why?
| | Cytarabine | 1 | 2018 | 66 | 0.030 |
Why?
| | GATA4 Transcription Factor | 1 | 2018 | 19 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2018 | 126 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2018 | 73 | 0.030 |
Why?
| | Biotinylation | 1 | 2017 | 37 | 0.030 |
Why?
| | Inflammation | 1 | 2009 | 2876 | 0.030 |
Why?
| | Internet | 1 | 2003 | 689 | 0.030 |
Why?
| | A549 Cells | 1 | 2018 | 74 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2018 | 63 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2017 | 50 | 0.030 |
Why?
| | Lymphocyte Subsets | 1 | 2017 | 77 | 0.030 |
Why?
| | Antigens, CD | 1 | 2020 | 558 | 0.030 |
Why?
| | Oncogene Protein pp60(v-src) | 1 | 2016 | 4 | 0.030 |
Why?
| | Mice, Nude | 2 | 2010 | 679 | 0.030 |
Why?
| | Pharmacogenetics | 1 | 2018 | 174 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2016 | 42 | 0.030 |
Why?
| | Phosphorylation | 1 | 2021 | 1706 | 0.030 |
Why?
| | Macaca | 1 | 2016 | 66 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2016 | 132 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 507 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2020 | 529 | 0.030 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 68 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2021 | 544 | 0.030 |
Why?
| | Immunogenetic Phenomena | 1 | 2016 | 8 | 0.030 |
Why?
| | Cell Fractionation | 1 | 2016 | 50 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1066 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2020 | 728 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1079 | 0.030 |
Why?
| | RNA Polymerase III | 1 | 2016 | 34 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2010 | 1261 | 0.030 |
Why?
| | Mice, Inbred NOD | 2 | 2008 | 613 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2015 | 132 | 0.030 |
Why?
| | Heterochromatin | 1 | 2015 | 66 | 0.030 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2014 | 6 | 0.030 |
Why?
| | Transcriptional Activation | 2 | 2010 | 372 | 0.030 |
Why?
| | Lipids | 1 | 2020 | 706 | 0.030 |
Why?
| | Blood | 1 | 2015 | 107 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1597 | 0.030 |
Why?
| | DNA Repair | 1 | 2017 | 254 | 0.030 |
Why?
| | Genes, Suppressor | 1 | 2014 | 4 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 117 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2014 | 72 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 926 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 247 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 396 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2015 | 230 | 0.030 |
Why?
| | Precipitin Tests | 2 | 2004 | 90 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2017 | 478 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1185 | 0.030 |
Why?
| | Membrane Transport Proteins | 1 | 2015 | 153 | 0.030 |
Why?
| | Computer Simulation | 1 | 2018 | 1002 | 0.030 |
Why?
| | RNA Editing | 1 | 2014 | 26 | 0.030 |
Why?
| | Eosinophils | 1 | 2016 | 316 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2020 | 933 | 0.030 |
Why?
| | Nucleosomes | 1 | 2015 | 163 | 0.030 |
Why?
| | Autoimmunity | 1 | 2020 | 932 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 382 | 0.030 |
Why?
| | RNA Isoforms | 1 | 2013 | 2 | 0.020 |
Why?
| | Blotting, Western | 1 | 2016 | 1177 | 0.020 |
Why?
| | Virus Replication | 1 | 2016 | 519 | 0.020 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2017 | 293 | 0.020 |
Why?
| | HapMap Project | 1 | 2013 | 4 | 0.020 |
Why?
| | Ataxins | 1 | 2013 | 4 | 0.020 |
Why?
| | Ataxin-1 | 1 | 2013 | 4 | 0.020 |
Why?
| | RNA Cap-Binding Proteins | 1 | 2013 | 3 | 0.020 |
Why?
| | ELAV Proteins | 1 | 2013 | 14 | 0.020 |
Why?
| | Toll-Like Receptor 5 | 1 | 2013 | 18 | 0.020 |
Why?
| | Flagellin | 1 | 2013 | 19 | 0.020 |
Why?
| | Neurogenesis | 1 | 2014 | 157 | 0.020 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 86 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2013 | 383 | 0.020 |
Why?
| | Cell Cycle | 1 | 2016 | 596 | 0.020 |
Why?
| | Cytokines | 1 | 2020 | 2048 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 146 | 0.020 |
Why?
| | Lung | 2 | 2018 | 4101 | 0.020 |
Why?
| | Multigene Family | 1 | 2013 | 209 | 0.020 |
Why?
| | Codon | 1 | 2012 | 91 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 320 | 0.020 |
Why?
| | Acetylation | 1 | 2013 | 259 | 0.020 |
Why?
| | Tretinoin | 1 | 2013 | 125 | 0.020 |
Why?
| | RNA Folding | 1 | 2012 | 35 | 0.020 |
Why?
| | History, 21st Century | 1 | 2013 | 220 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2351 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 33 | 0.020 |
Why?
| | Genetic Research | 1 | 2011 | 17 | 0.020 |
Why?
| | History, 20th Century | 1 | 2013 | 327 | 0.020 |
Why?
| | 3T3 Cells | 1 | 2012 | 156 | 0.020 |
Why?
| | Adipose Tissue, White | 1 | 2012 | 42 | 0.020 |
Why?
| | Data Mining | 1 | 2012 | 113 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2011 | 43 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 254 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2012 | 170 | 0.020 |
Why?
| | Adipose Tissue, Brown | 1 | 2012 | 60 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2013 | 288 | 0.020 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2012 | 57 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 191 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 207 | 0.020 |
Why?
| | Skin Diseases | 1 | 2012 | 152 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 382 | 0.020 |
Why?
| | PPAR gamma | 1 | 2012 | 178 | 0.020 |
Why?
| | Neutrophils | 1 | 2016 | 1123 | 0.020 |
Why?
| | Gene Dosage | 1 | 2011 | 145 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2013 | 226 | 0.020 |
Why?
| | Zygote | 1 | 2010 | 14 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2013 | 474 | 0.020 |
Why?
| | Bias | 1 | 2011 | 197 | 0.020 |
Why?
| | Lipopeptides | 1 | 2009 | 16 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2010 | 246 | 0.020 |
Why?
| | Poly I-C | 1 | 2009 | 58 | 0.020 |
Why?
| | Career Choice | 1 | 2011 | 234 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2009 | 80 | 0.020 |
Why?
| | Oncogene Proteins v-myb | 1 | 2009 | 1 | 0.020 |
Why?
| | HMGB3 Protein | 1 | 2009 | 1 | 0.020 |
Why?
| | Mice, SCID | 1 | 2010 | 369 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4282 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 302 | 0.020 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2009 | 56 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 365 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2009 | 117 | 0.020 |
Why?
| | Lacrimal Apparatus | 1 | 2008 | 9 | 0.020 |
Why?
| | Models, Animal | 1 | 2010 | 393 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2009 | 193 | 0.020 |
Why?
| | Salivary Glands | 1 | 2008 | 36 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2009 | 130 | 0.020 |
Why?
| | Polyribosomes | 1 | 2008 | 22 | 0.020 |
Why?
| | Secretory Vesicles | 1 | 2008 | 24 | 0.020 |
Why?
| | Vacuoles | 1 | 2008 | 38 | 0.020 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 17 | 0.020 |
Why?
| | Leukocytes | 1 | 2009 | 296 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2008 | 216 | 0.020 |
Why?
| | Eye | 1 | 2008 | 112 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 159 | 0.020 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2007 | 64 | 0.020 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2009 | 212 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2007 | 171 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 505 | 0.020 |
Why?
| | Actins | 1 | 2008 | 424 | 0.010 |
Why?
| | Uveitis | 1 | 2006 | 149 | 0.010 |
Why?
| | Survival Rate | 1 | 2010 | 2087 | 0.010 |
Why?
| | Glucose | 1 | 2010 | 1048 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 2004 | 187 | 0.010 |
Why?
| | Colforsin | 1 | 2004 | 47 | 0.010 |
Why?
| | Transcription Factor RelA | 1 | 2003 | 86 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2857 | 0.010 |
Why?
| | Quality Improvement | 1 | 2011 | 1293 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 4310 | 0.010 |
Why?
| | Shal Potassium Channels | 1 | 2000 | 5 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2000 | 57 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1368 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 318 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 2335 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1216 | 0.010 |
Why?
| | Middle Aged | 1 | 2010 | 36126 | 0.000 |
Why?
|
|
Rinn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|